Literature DB >> 24898554

Research progress in signalling pathway in diabetic nephropathy.

Wei-Jian Ni1, Li-Qin Tang, Wei Wei.   

Abstract

Diabetic nephropathy, a lethal diabetic complication, is a leading cause of end-stage renal disease, which is pathologically characterized by thickened tubular basal and glomerular membranes, accumulated extracellular matrix, and progressive mesangial hypertrophy. Growing evidence indicates that diabetic nephropathy is induced by multiple conditions, such as glucose metabolism disorder, oxidative stress, numerous inflammatory factors and cytokines, and haemodynamic changes that lead to the occurrence and development of diabetic nephropathy based on genetic susceptibility. A variety of abnormalities in the signalling pathway may interact to produce these pathologic processes. Research has aimed to highlight the signalling pathway mechanisms that lead to diabetic nephropathy so that preventative strategies and effective therapies might be developed. In this review, important pathways that appear to be involved in driving these processes are discussed.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetic nephropathy; glomerular mesangial cell; podocyte; renal fibrosis; signalling pathway

Mesh:

Year:  2015        PMID: 24898554     DOI: 10.1002/dmrr.2568

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  24 in total

Review 1.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

2.  Screening of Diabetic Nephropathy Progression-Related Genes Based on Weighted Gene Co-expression Network Analysis.

Authors:  Ling'an Yu; Haiying Tao
Journal:  Biochem Genet       Date:  2022-07-14       Impact factor: 2.220

3.  Circ_0060077 Knockdown Alleviates High-Glucose-Induced Cell Apoptosis, Oxidative Stress, Inflammation and Fibrosis in HK-2 Cells via miR-145-5p/VASN Pathway.

Authors:  Jinjin Zhou; Xia Peng; Yanhai Ru; Jiayun Xu
Journal:  Inflammation       Date:  2022-06-21       Impact factor: 4.657

Review 4.  Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease.

Authors:  Yu Yang; Hui Huang; Zheng Xu; Jun-Kai Duan
Journal:  J Diabetes Res       Date:  2017-08-08       Impact factor: 4.011

5.  Resistin-Like Molecule Beta (RELM-β) Regulates Proliferation of Human Diabetic Nephropathy Mesangial Cells via Mitogen-Activated Protein Kinases (MAPK) Signaling Pathway.

Authors:  Yun-Qian Wang; Cong-Cong Fan; Bao-Ping Chen; Jun Shi
Journal:  Med Sci Monit       Date:  2017-08-12

6.  MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin.

Authors:  Jia Guo; Jing Li; Jing Zhao; Shuguang Yang; Luyao Wang; Genyang Cheng; Dong Liu; Jing Xiao; Zhangsuo Liu; Zhanzheng Zhao
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

7.  Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury.

Authors:  Heba El Gamal; Ali Hussein Eid; Shankar Munusamy
Journal:  Biomed Res Int       Date:  2017-03-12       Impact factor: 3.411

8.  Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.

Authors:  Wei-Jian Ni; Li-Qin Tang; Hong Zhou; Hai-Hua Ding; Yuan-Ye Qiu
Journal:  J Cell Mol Med       Date:  2016-04-21       Impact factor: 5.310

9.  T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.

Authors:  Jyoti Rani; Inna Mittal; Atreyi Pramanik; Namita Singh; Namita Dube; Smriti Sharma; Bhanwar Lal Puniya; Muthukurussi Varieth Raghunandanan; Ahmed Mobeen; Srinivasan Ramachandran
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

Review 10.  Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.

Authors:  Jiarong Lv; Yu Wu; Yifeng Mai; Shizhong Bu
Journal:  J Diabetes Res       Date:  2020-06-19       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.